1. Home
  2. CCSI vs VALN Comparison

CCSI vs VALN Comparison

Compare CCSI & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consensus Cloud Solutions Inc.

CCSI

Consensus Cloud Solutions Inc.

HOLD

Current Price

$29.70

Market Cap

493.6M

Sector

Technology

ML Signal

HOLD

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$6.16

Market Cap

536.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCSI
VALN
Founded
2021
2012
Country
United States
France
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
493.6M
536.9M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
CCSI
VALN
Price
$29.70
$6.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$37.50
$15.50
AVG Volume (30 Days)
148.2K
33.7K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.30
N/A
Revenue
$349,696,000.00
N/A
Revenue This Year
$3.33
N/A
Revenue Next Year
$2.70
$93.87
P/E Ratio
$21.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.42
$5.06
52 Week High
$37.30
$12.25

Technical Indicators

Market Signals
Indicator
CCSI
VALN
Relative Strength Index (RSI) 56.80 53.90
Support Level $25.35 $5.81
Resistance Level $30.30 $6.53
Average True Range (ATR) 2.21 0.24
MACD -0.07 0.12
Stochastic Oscillator 32.92 62.05

Price Performance

Historical Comparison
CCSI
VALN

About CCSI Consensus Cloud Solutions Inc.

Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in the fax cloud business. The company's offerings include communication, data extraction, and digital signature solutions that enable users to securely access, exchange, and manage information across organizational and geographic boundaries. It serves multiple industry verticals, including healthcare, government, financial services, legal, and education. Geographically, the company operates in the United States, Canada, Ireland, and other countries. It derives the maximum revenue from the United States.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: